Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transfusion in patients with hemoglobinopathies].

M de Montalembert1

  • 1Service de pédiatrie générale, hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|February 24, 2001
PubMed
Summary

Thalassemia and sickle cell disease management in France relies heavily on blood transfusions. Regular transfusions maintain hemoglobin levels for patients, while managing complications like alloimmunization is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.

Blood·2020
Same author

Vaso-occlusive crisis of the temporo-mandibular joint: An unusual finding in sickle cell disease.

Journal of stomatology, oral and maxillofacial surgery·2020
Same author

Transfusing children with hemoglobinopathies.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Management of iron overload in hemoglobinopathies.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2017
Same author

Time perception of simultaneous and sequential events in early-onset schizophrenia.

Neurocase·2016
Same author

[Time perception and schizophrenia: Phenomenological and neuropsychological approach].

L'Encephale·2016

Area of Science:

  • Hematology
  • Transfusion Medicine

Context:

  • Focuses on thalassemia and sickle cell disease management in France.
  • Highlights the reduced incidence of major thalassemia due to screening and prenatal diagnosis.
  • Addresses the significant population of sickle cell disease patients requiring transfusion therapy.

Purpose:

  • To outline the transfusion strategies for thalassemia and sickle cell disease.
  • To discuss the indications and protocols for regular and intermittent blood transfusions.
  • To identify challenges such as alloimmunization in sickle cell patients.

Summary:

  • Thalassemia management involves maintaining hemoglobin levels (Hb > 10 g/dL) via erythrocyte concentrate transfusions, with adjustments for autoantibodies.
  • Intermediate thalassemia patients receive transfusions for anemia exacerbation or intolerance.

Related Experiment Videos

  • Sickle cell disease treatment includes simple transfusions for specific conditions and exchange transfusions for severe events or surgery preparation, aiming to maintain baseline hematocrit.

    • Impact:

    • Blood transfusions are critical for preventing complications like cerebrovascular accidents in sickle cell disease.
    • Increased alloimmunization prevalence in sickle cell patients necessitates careful donor-recipient matching.
    • Effective transfusion protocols are essential for improving quality of life and managing chronic anemia in these patient populations.